JBF Capital’s Inhibrx INBX Stock Holding History

JBF Capital’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,949	Closed	-$299K	–	85
2025 Q2	$299K	Hold	20,949	–	–	0.05%	49
2025 Q1	$293K	Hold	20,949	–	–	0.06%	47
2024 Q4	$323K	Hold	20,949	–	–	0.06%	52
2024 Q3	$328K	Hold	20,949	–	–	0.05%	66
2024 Q2	$297K	Buy	+20,949	New	+$327K	0.05%	67

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JBF Capital's INBX Position: Q3 2025 in Review

JBF Capital sold out of Inhibrx (INBX) in Q3 2025, closing a stake of 20,949 shares — an estimated $299K sold.

JBF Capital first reported a position in INBX in Q2 2024 and held it in 5 quarters. The position peaked at $328K in Q3 2024. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2025.

JBF Capital reported no remaining Inhibrx position as of Q3 2025 after selling out during the quarter.
JBF Capital sold 20,949 Inhibrx shares in Q3 2025, an estimated $299K.
JBF Capital first reported a position in Inhibrx in Q2 2024 and held it in 5 quarters.
JBF Capital's Inhibrx position peaked at $328K in Q3 2024.
102 funds tracked by Wall St. Rank held Inhibrx as of Q3 2025.

Based on JBF Capital's 13F filing for Q3 2025, filed 13 Nov 2025.